Patients with irritable bowel syndrome-diarrhea have lower disease-specific quality of life than irritable bowel syndrome-constipation

被引:72
作者
Singh, Prashant [1 ]
Staller, Kyle [1 ]
Barshop, Kenneth [2 ]
Dai, Elaine [1 ]
Newman, Jennifer [1 ]
Yoon, Sonia [3 ]
Castel, Shahar [1 ]
Kuo, Braden [1 ]
机构
[1] Massachussets Gen Hosp, GI Unit, Dept Med, Boston, MA 02124 USA
[2] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA
[3] Weill Cornell Med Coll, Div Gastroenterol, New York, NY 10021 USA
关键词
Irritable bowel syndrome; Irritable bowel syndrome subtype; Quality of life; Irritable bowel syndrome-quality of life; Constipation; Diarrhea; FUNCTIONAL GASTROINTESTINAL DISORDERS; IBS PATIENTS; UNITED-STATES; IMPACT; PREVALENCE; SYMPTOMS; HABIT; VALIDATION; PATTERNS; THERAPY;
D O I
10.3748/wjg.v21.i26.8103
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To determine effect of irritable bowel syndrome (IBS) subtype on IBS-specific quality of life (QOL) questionnaire and its subscales. METHODS: We studied IBS patients visiting our functional gastroenterology disorder clinic at a tertiary care center of Unites States. IBS and IBS subtype were diagnosed using Rome-. questionnaire. QOL was assessed using IBS-QOL questionnaire. IBS-QOL assesses quality of life along eight subscales: dysphoria, interference with activities, body image, health worry, food avoidance, social reactions, sexual health, and effect on relationships. IBS-QOL and its subscales were both scored on a range of 0-100 with higher scores suggestive of better QOL. Results of overall IBS-QOL scores and subscale scores are expressed as means with 95% CI. We compared mean IBS-QOL score and its subscales among various IBS-subtypes. Analysis of variance (ANOVA) was used to compare the mean difference between more than two groups after controlling for age and gender. A post-hoc analysis using Bonferroni correction was used only when P value for ANOVA was less than 0.05. RESULTS: Of 542 patients screened, 243 had IBS as per Rome-. criteria. IBS-mixed (IBS-M) was the most common IBS subtype (121 patients, 49.8%) followed by IBS-diarrhea (IBS-D) (56 patients, 23.1%), IBS-constipation (IBS-C) (54 patients, 22.2%) and IBS-unspecified (IBS-U) (12 patients, 4.9%). Overall IBS-QOL scores were significantly different among various IBS-subtypes (P = 0.01). IBS-QOL of patients with IBS-D (61.6, 95% CI: 54.0-69.1) and IBS-M (63.0, 95% CI: 58.1-68.0) was significantly lower than patients with IBS-C (74.5, 95% CI: 66.9-82.1) (P = 0.03 and 0.02 respectively). IBS-D patients scored significantly lower than IBS-C on food avoidance (45.0, 95% CI: 34.8-55.2 vs 61.1, 95% CI: 50.8-71.3, P = 0.04) and interference with activity (59.6, 95% CI: 51.4-67.7 vs 82.3, 95% CI: 74.1-90.6, P < 0.001). IBS-M patients had more interference in their activities (61.6, 95% CI: 56.3-66.9 vs 82.3, 95% CI: 74.1-90.6, P = 0.001) and greater impact on their relationships (73.3, 95% CI: 68.4-78.2 vs 84.7, 95% CI: 77.2-92.2, P = 0.02) than IBS-C patients. Patients with IBS-M also scored significantly lower than IBS-C on food avoidance (47.2, 95% CI: 40.7-53.7 vs 61.1, 95% CI: 50.8-71.3, P = 0.04) and social reaction (66.1, 95% CI: 61.1-71.1 vs 80.0, 95% CI: 72.1-87.7, P = 0.005). CONCLUSION: IBS-D and IBS-M patients have lower IBS-QOL than IBS-C patients. Clinicians should recognize food avoidance, effects on daily activities and relationship problems in these patients.
引用
收藏
页码:8103 / 8109
页数:7
相关论文
共 36 条
[1]   Self-Reported Food-Related Gastrointestinal Symptoms in IBS Are Common and Associated With More Severe Symptoms and Reduced Quality of Life [J].
Bohn, Lena ;
Storsrud, Stine ;
Tornblom, Hans ;
Bengtsson, Ulf ;
Simren, Magnus .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 (05) :634-641
[2]   Review article: the economic impact of the irritable bowel syndrome [J].
Canavan, C. ;
West, J. ;
Card, T. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 40 (09) :1023-1034
[3]   Anxiety, Depression and Quality of Life in Patients with Irritable Bowel Syndrome [J].
Cho, Hyun Sun ;
Park, Jae Myung ;
Lim, Chul Hyun ;
Cho, Yu Kyung ;
Lee, In Seok ;
Kim, Sang Woo ;
Choi, Myung-Gyu ;
Chung, In-Sik ;
Chung, Yun Kyung .
GUT AND LIVER, 2011, 5 (01) :29-36
[4]   Randomised clinical trial: alosetron improves quality of life and reduces restriction of daily activities in women with severe diarrhoea-predominant IBS [J].
Cremonini, F. ;
Nicandro, J. P. ;
Atkinson, V. ;
Shringarpure, R. ;
Chuang, E. ;
Lembo, A. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (05) :437-448
[5]   UNITED-STATES HOUSEHOLDER SURVEY OF FUNCTIONAL GASTROINTESTINAL DISORDERS - PREVALENCE, SOCIODEMOGRAPHY, AND HEALTH IMPACT [J].
DROSSMAN, DA ;
LI, ZM ;
ANDRUZZI, E ;
TEMPLE, RD ;
TALLEY, NJ ;
THOMPSON, WG ;
WHITEHEAD, WE ;
JANSSENS, J ;
FUNCHJENSEN, P ;
CORAZZIARI, E ;
RICHTER, JE ;
KOCH, GG .
DIGESTIVE DISEASES AND SCIENCES, 1993, 38 (09) :1569-1580
[6]   Health-related quality of life among persons with irritable bowel syndrome: a systematic review [J].
El-Serag, HB ;
Olden, K ;
Bjorkman, D .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 (06) :1171-1185
[7]   Irritable bowel syndrome symptoms and health related quality of life in female veterans [J].
Graham, D. P. ;
Savas, L. ;
White, D. ;
El-Serag, R. ;
Laday-Smith, S. ;
Tan, G. ;
El-Serag, H. B. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 31 (02) :261-273
[8]   The impact of irritable bowel syndrome on health-related quality of life [J].
Gralnek, IM ;
Hays, RD ;
Kilbourne, A ;
Naliboff, B ;
Mayer, EA .
GASTROENTEROLOGY, 2000, 119 (03) :654-660
[9]   Evaluation of a new quality of life questionnaire for patients with irritable bowel syndrome [J].
Hahn, BA ;
Kirchdoerfer, LJ ;
Fullerton, S ;
Mayer, E .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1997, 11 (03) :547-552
[10]   Low FODMAP Diet in the Treatment of Irritable Bowel Syndrome: Is It the End of the Road or the Beginning of a Journey? Reply [J].
Halmos, Emma P. ;
Muir, Jane G. ;
Gibson, Peter R. .
GASTROENTEROLOGY, 2014, 146 (07) :1830-1831